AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,412 | -91.2% | 11,718 | -72.2% | 0.00% | -100.0% |
| Q4 2021 | $95,254 | -31.4% | 42,148 | -12.6% | 0.00% | -50.0% |
| Q3 2021 | $138,856 | +31.1% | 48,214 | +72.5% | 0.00% | +100.0% |
| Q2 2021 | $105,949 | -28.3% | 27,955 | -36.0% | 0.00% | -50.0% |
| Q1 2021 | $147,748 | +138.3% | 43,648 | +97.1% | 0.00% | +100.0% |
| Q4 2020 | $62,009 | +32.8% | 22,146 | +19.1% | 0.00% | 0.0% |
| Q3 2020 | $46,676 | -91.4% | 18,596 | -53.7% | 0.00% | -90.0% |
| Q2 2020 | $545,549 | +95.3% | 40,173 | +9.0% | 0.01% | +66.7% |
| Q1 2020 | $279,399 | +14.6% | 36,860 | -4.4% | 0.01% | +50.0% |
| Q4 2019 | $243,769 | +108.9% | 38,571 | +29.6% | 0.00% | +100.0% |
| Q3 2019 | $116,671 | -31.3% | 29,763 | -15.2% | 0.00% | -33.3% |
| Q2 2019 | $169,797 | -36.0% | 35,082 | +8.3% | 0.00% | -40.0% |
| Q1 2019 | $265,290 | +48.0% | 32,392 | -0.0% | 0.01% | +25.0% |
| Q4 2018 | $179,190 | -2.2% | 32,403 | +56.1% | 0.00% | +33.3% |
| Q3 2018 | $183,302 | -99.9% | 20,759 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $207,174,000 | +53.3% | 20,759 | +46.4% | 0.00% | +50.0% |
| Q1 2018 | $135,144,000 | +63949.3% | 14,181 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $211,000 | -64.2% | 14,181 | -52.6% | 0.00% | -25.0% |
| Q3 2017 | $589,000 | +72.2% | 29,941 | +25.7% | 0.00% | +100.0% |
| Q2 2017 | $342,000 | +18.8% | 23,824 | -24.0% | 0.00% | 0.0% |
| Q1 2017 | $288,000 | -13.0% | 31,340 | -1.4% | 0.00% | 0.0% |
| Q4 2016 | $331,000 | +14.9% | 31,800 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $288,000 | +13.4% | 31,800 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $254,000 | -17.0% | 33,982 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $306,000 | +27.0% | 33,982 | +82.3% | 0.00% | 0.0% |
| Q4 2015 | $241,000 | +1168.4% | 18,636 | +854.7% | 0.00% | – |
| Q3 2015 | $19,000 | -90.2% | 1,952 | -89.7% | 0.00% | -100.0% |
| Q2 2015 | $194,000 | -24.8% | 18,890 | +103.4% | 0.00% | -50.0% |
| Q2 2014 | $258,000 | – | 9,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |